News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

New Biosensing Film Can Diagnose Both Viral and Bacterial Infections Cheaply and Without the Need for Traditional Clinical Pathology Laboratory Tests

Researchers at Florida Atlantic University believe this technology could also be used to detect bacteria in food and water and to follow patients’ progress after leaving acute or outpatient care

New technology could shift the paradigm in infectious disease testing by clinical laboratories, while also giving hospitals a faster way to identify hospital-acquired infections (HAIs) and monitor patients for infections post-discharge. The diagnostic technology is built into a special “biosensing film” made of cellulose paper and a flexible polymer.

Researchers at Florida Atlantic University (FAU) developed the biosensing film. They say it can detect and discern HIV, Staphylococcus aureus, E-coli and other bacteria in blood, plasma, and saliva. The test is inexpensive, disposable, and portable. Best of all (at least for developing countries, remote locations, and places that have few resources), it requires no expensive infrastructure or a clinical laboratory.

And yes, the biosensing film is designed to work in tandem with a smartphone app. But in this case, the mobile app is only part of the story. The real genius is the piece of lightweight, flexible, “electronic paper” or “biosensing film” used with the app. The film acts as a platform that detects infections, both viral and bacterial.

The story of this inventive biosensing film is detailed in a Scientific Reports article in the March 5, 2015, edition of Nature. (more…)

Mobile Apps for Corporate Health Programs Create Great Patient Engagement and Participation

Clinical laboratories have an opportunity to provide medical laboratory test services to employer-sponsored wellness programs

Venture capitalists are beginning to pour dollars into mobile apps designed to support corporate health and wellness. For savvy pathologists and clinical laboratory managers, this represents an opportunity to serve a cash-paying market for medical laboratory testing.

Another aspect of this trend which may be worth studying by pathologists and clinical laboratory administrators is the use of “gamification” by these mobile app developers. Gamification uses technologies and programming to more deeply engage the user, just as a video game does.

Corporate wellness platform Keas of San Francisco, California, recently announced an $8-million investment round, according to a story at Ignition Partners and Atlas Ventures provided the capital. With this latest round of funding, investors have $25.5 million invested in Keas. (more…)

Physicians Embrace mHealth Technology, Creating New Opportunities for Clinical Laboratories to Add Value

Mobile health devices can allow physicians to consult with pathologists in real time

Mobile-health technology (mHealth) is the hot ticket with physicians. The advent of mobile computing, smartphones, and iPad-types of devices are fueling a strong demand by physicians for mobile apps that can help them receive alerts, stay informed of patient progress, access lab test results, and contact patients.

This is a swift-moving trend and clinical laboratory managers will want to develop information technology (IT) strategies to serve this keen interest by physicians to use their mobile-health devices to order medical laboratory tests and receive laboratory test results.